Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
British Journal of Haematology | Wiley Online Library
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Guide to Antibody structure and isotypes | Abcam
JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
Immunoglobulin Light Chain - an overview | ScienceDirect Topics
Polyclonal versus monoclonal immunoglobulin-free light chains quantification - Giuseppe Di Noto, Elena Cimpoies, Alessandra Dossi, Lucia Paolini, Annalisa Radeghieri, Luigi Caimi, Doris Ricotta, 2015
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
Nephron Power: February 2016
Measuring M-Protein SPEP, UPEP Tests | Int'l Myeloma Fdn
Providence Health Care Test Catalog
APC Mouse anti-Human Ig, κ Light Chain
![Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam](https://www.abcam.com/ps/products/124/ab124727/Images/ab124727-8-anti-kappa-light-chain-antibody-epr5367-8-elisa.jpg "Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam")
Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Living With - HealthTree for Multiple Myeloma
Frontiers | High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US
Sebia FLC Kappa, Serum free light chain quantification
SARS-CoV-2 infection associated with monoclonal gammopathy. A case report based on the study of minimally invasive ultrasound-guided autopsy | Revista Española de Patología
